Swedish Pharmaceuticals & Biotech High Growth Potential Companies

Ascelia Pharma

Market Cap: SEK 263.3m

A biotech company, focuses on orphan oncology treatments in Sweden.

Camurus

Market Cap: SEK 31.9b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.

Corline Biomedical

Market Cap: SEK 211.6m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Elicera Therapeutics

Market Cap: SEK 148.5m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Xbrane Biopharma

Market Cap: SEK 301.8m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Bonesupport Holding

Market Cap: SEK 19.2b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Devyser Diagnostics

Market Cap: SEK 1.4b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

BioArctic

Market Cap: SEK 14.6b

Develops biological drugs for patients with disorders of the central nervous system in Sweden.

Newbury Pharmaceuticals

Market Cap: SEK 81.3m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 168.6m

Operates as a pharmaceutical company.

SenzaGen

Market Cap: SEK 128.9m

Provides non-animal tests for assessing a substance’s allergenicity.

BioInvent International

Market Cap: SEK 1.8b

A clinical-stage company, discovers, researches, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Active Biotech

Market Cap: SEK 88.4m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Egetis Therapeutics

Market Cap: SEK 1.4b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Moberg Pharma

Market Cap: SEK 330.4m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Xspray Pharma

Market Cap: SEK 1.1b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

AddLife

Market Cap: SEK 17.6b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

Orexo

Market Cap: SEK 483.1m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally.

Modus Therapeutics Holding

Market Cap: SEK 44.4m

A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.

Magle Chemoswed Holding

Market Cap: SEK 558.0m

Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.

BioGaia

Market Cap: SEK 9.9b

A healthcare company, provides probiotic products worldwide.

Swedencare

Market Cap: SEK 5.6b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

BICO Group

Market Cap: SEK 2.5b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

AlzeCure Pharma

Market Cap: SEK 215.4m

A pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

FluoGuide

Market Cap: SEK 557.1m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

Lipigon Pharmaceuticals

Market Cap: SEK 18.4m

Develops drugs for lipid related diseases in Sweden.

Genovis AB (publ.)

Market Cap: SEK 1.2b

Develops and sells tools for the development of new treatment methods and diagnostics for customers in the pharmaceutical and research industries.

Vitrolife

Market Cap: SEK 20.6b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

SynAct Pharma

Market Cap: SEK 960.6m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Cantargia

Market Cap: SEK 323.2m

A biotechnology company, develops antibody-based treatments for life threatening diseases.

Biotage

Market Cap: SEK 7.0b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

Swedish Orphan Biovitrum

Market Cap: SEK 87.3b

An integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Guard Therapeutics International

Market Cap: SEK 247.1m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Lipum

Market Cap: SEK 348.9m

A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.